New York Genome Center Inc

Analysis

New York Genome Center Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in January 2012, 14 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, New York Genome Center Inc reported income of $92.9m and spending of $81.9m, spending 88% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $42.2m to $92.9m (+120%), an average of +22% a year. The sharpest change came in the year to December 2020, when income rose by 44%. Over the whole period it spent 112% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, New York Genome Center Inc sits at the 95th percentile: it is larger than about 95% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 99th percentile within NY. Charities of a similar size with the same main cause include Casa Colina Hospital and Centers for Healthcare ($92.9m), North Arkansas Regional Medical Center ($93.0m) and Hearthstone Senior Communities Inc ($92.9m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 88% and program service revenue 10% of the total. Compensation of current officers, directors and key employees was $4.4m (5.3% of expenses). Other salaries and wages came to $22.7m. It paid $14k in professional fundraising fees. At year end it held assets of $184.1m against liabilities of $138.1m, net assets of $45.9m. It reported 224 employees.